Cargando…
Concomitant benzodiazepine and opioids decrease sleep apnoea risk in chronic pain patients
BACKGROUND: The concurrent use of sedating centrally acting drugs and opioids by chronic pain patients occurs routinely despite concerns of negative impacts on respiration during sleep. The effects of centrally acting drugs and opioids on sleep apnoea have not been well characterised. The objective...
Autores principales: | Mir, Soodaba, Wong, Jean, Ryan, Clodagh M., Bellingham, Geoff, Singh, Mandeep, Waseem, Rida, Eckert, Danny J., Chung, Frances |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445118/ https://www.ncbi.nlm.nih.gov/pubmed/32864381 http://dx.doi.org/10.1183/23120541.00093-2020 |
Ejemplares similares
-
Predictive factors for sleep apnoea in patients on opioids for chronic pain
por: Chung, Frances, et al.
Publicado: (2019) -
Opioid Safety and Concomitant Benzodiazepine Use in End-Stage Renal Disease Patients
por: Ruchi, Rupam, et al.
Publicado: (2019) -
Concomitant Obstructive Sleep Apnoea in Patients with Meniere's Disease: A Case Report and Literature Review
por: Low, Wong Kein, et al.
Publicado: (2021) -
Sleep apnoea
por: Jun, Jonathan C., et al.
Publicado: (2016) -
Sleep Apnoea
por: Wight, Jeremy
Publicado: (1999)